Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • dsher
    Member
    • Feb 2013
    • 23

    #1

    Comparing metagenomes produces with different sequencing technologies

    Hi all,

    I would like to compare the abundance of my gene(s) of interest across many published metagenomes. Typically we would normalize the number of hits to the gene length and number of sequences (or mbp) to get relative abundances, and perhaps also normalize to the abundance of single-copy core genes to get an estimate of the gene number per genome equivalents. This has been done many times, but to the best of my knowledge all such comparison were between metagenomes sequenced using the same technology (e.g. within the GOS dataset, which is all Sanger).

    My question is, can this approach be extended to compare across metagenomes produced with different sequencing technologies (e.g. compare the relative abundance in a marine metagenome sequenced with Sanger to human gut sample sequenced with Illumina)? Are such comparisons valid between samples with very different sequencing coverage? There must be some intelligent controls one would have to run... any suggestions welcome! Also, if anyone is aware of publications where such comparisons have been performed I would love to hear about them!

    Thanks
    Daniel
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    Originally posted by dsher View Post
    My question is, can this approach be extended to compare across metagenomes produced with different sequencing technologies (e.g. compare the relative abundance in a marine metagenome sequenced with Sanger to human gut sample sequenced with Illumina)? Are such comparisons valid between samples with very different sequencing coverage?
    I'm an author of an upcoming paper that does something along these lines. Generally, I think it's a bad idea to quantify across platforms like that. You will run into a lot of variable GC-related coverage bias, which is nonlinear and hard to compensate for.

    Comment

    • dsher
      Member
      • Feb 2013
      • 23

      #3
      Thanks Brian. Do these difficulties extend also to comparing between different versions of the same sequencing technique (e.g. between HiSeq and MySeq or between HiSeq or 454 versions as they evolve to provide different read lengths)?

      Also, I would really be grateful if you could share the info on this publication (perhaps on this thread?) once it is publically available.

      Cheers
      Daniel

      Comment

      • Brian Bushnell
        Super Moderator
        • Jan 2014
        • 2709

        #4
        Originally posted by dsher View Post
        Thanks Brian. Do these difficulties extend also to comparing between different versions of the same sequencing technique (e.g. between HiSeq and MySeq or between HiSeq or 454 versions as they evolve to provide different read lengths)?
        To be honest, yes, unfortunately - different versions of Illumina chemistry have different GC biases; newer versions tend to have a lower bias than older ones. The read length shouldn't matter, but the chemistry does. I don't know if there is a substantial bias difference between chemistry versions on other platforms (454, Solid, PacBio), and probably some versions of Illumina chemistry are fairly equivalent to other versions and could be compared, but others definitely are not.

        Also, I would really be grateful if you could share the info on this publication (perhaps on this thread?) once it is publically available.
        It will be submitted this week, so hopefully that will be soon!

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        34 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Working...